Atlas Trials

Paclitaxel and Carboplatin With or Without Metformin Hydrochloride in Treating Patients With Stage III, IV, or Recurrent Endometrial Cancer

Clinical trial NCT02065687 · UNKNOWN

Trial details

NCT number
NCT02065687
Sponsor
Gynecologic Oncology Group
Status
UNKNOWN
Phase
Phase 2, Phase 3
Study type
INTERVENTIONAL
Endometrial AdenocarcinomaEndometrial Clear Cell AdenocarcinomaEndometrial Serous AdenocarcinomaEndometrial Undifferentiated CarcinomaRecurrent Uterine Corpus CarcinomaStage III Uterine Corpus Cancer AJCC v7Stage IIIA Uterine Corpus Cancer AJCC v7Stage IIIB Uterine Corpus Cancer AJCC v7Stage IIIC Uterine Corpus Cancer AJCC v7Stage IV Uterine Corpus Cancer AJCC v7Stage IVA Uterine Corpus Cancer AJCC v7Stage IVB Uterine Corpus Cancer AJCC v7
Start date
2014-03-17
Primary completion
2019-04-17
Enrollment
469

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.